NWBO — Northwest Biotherapeutics Inc · rev $1.3M

Northwest Biotherapeutics Inc (NWBO) is a biotechnology company listed on OTCQB.

Latest reported NWBO revenue for 2026-06-30 was $1.3M. Net income was -$12.3M. NWBO currently screens at market cap $312.2M.

Use this NWBO page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the NWBO quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the NWBO SEC filings page. Lician reads the product cache first so this HTML stays unique to Northwest Biotherapeutics Inc even when a live quote feed is slow.

Northwest Biotherapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full NWBO income, balance, and cash tables.

  • Revenue$1.4M
  • Net Income-$60.2M
  • Total Assets$26.7M
  • Total Debt$0
  • Free Cash Flow-$46.3M

NWBO recent filings